LBF20207PG39: Difference between revisions
No edit summary |
No edit summary |
||
| Line 11: | Line 11: | ||
|Chemical Synthesis= | |Chemical Synthesis= | ||
|Metabolism= | |Metabolism= | ||
|Biological Activity= 11-deoxy Prostaglandin | |Biological Activity= 11-deoxy Prostaglandin F2 alpha shows smooth muscle contraction effect in rabbit aorta, dog saphenous vein, guinea pig trachea.[[Reference:Jones_RL:Peesapati_V:Wilson_NH:,Br. J. Pharmacol.,1982,76,423|{{RelationTable/GetFirstAuthor|Reference:Jones_RL:Peesapati_V:Wilson_NH:,Br. J. Pharmacol.,1982,76,423}}]] | ||
}} | }} | ||
{{Lipid/Footer}} | {{Lipid/Footer}} | ||
Revision as of 14:00, 19 February 2010
| LipidBank Top (トップ) |
Fatty acid (脂肪酸) |
Glycerolipid (グリセロ脂質) |
Sphingolipid (スフィンゴ脂質) |
Journals (雑誌一覧) |
How to edit (ページの書き方) |
| IDs and Links | |
|---|---|
| LipidBank | XPR1760 |
| LipidMaps | LMFA03010078 |
| CAS | |
| KEGG | {{{KEGG}}} |
| KNApSAcK | {{{KNApSAcK}}} |
| mol | LBF20207PG39 |
| 11-deoxy Prostaglandin F_2α | |
|---|---|
| |
| Structural Information | |
| 9α,15S-dihydroxy-prosta-5Z,13E-dien-1-oic acid | |
| |
| Formula | C20H34O4 |
| Exact Mass | 338.24570957599997 |
| Average Mass | 338.48156 |
| SMILES | C(CC[C@@H](O)C=C[C@H]([C@H]1CC=CCCCC(O)=O)CC[C@H](O)1)CC |
| Physicochemical Information | |
| 11-deoxy Prostaglandin F2 alpha shows smooth muscle contraction effect in rabbit aorta, dog saphenous vein, guinea pig trachea. Jones_RL et al. | |
| Spectral Information | |
| Mass Spectra | |
| UV Spectra | |
| IR Spectra | |
| NMR Spectra | |
| Other Spectra | |
| Chromatograms | |
| Reported Metabolites, References | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
